Drug Type Biological products |
Synonyms- |
Target |
Action modulators |
Mechanism Ang2 modulators(Angiopoietin-2 modulators), VEGF-A modulators(Vascular endothelial growth factor A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dystrophy, Macular | Preclinical | China | 21 Mar 2022 | |
Dystrophy, Macular | Preclinical | China | 21 Mar 2022 |